Írsko - angličtina - HPRA (Health Products Regulatory Authority)

pco manufacturing - codeine phosphate hemihydrate paracetamol - capsules hard - 30/500 milligram

Malta - angličtina - Malta Medicines Authority

forest laboratories uk limited - dimeticone - oral suspension - dimeticone 40 mg/ml - drugs for functional gastrointestinal disorders

Malta - angličtina - Malta Medicines Authority

bayer plc - calcium carbonate; dimeticone; magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg; dimeticone 25 mg; magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Malta - angličtina - Malta Medicines Authority

forest laboratories uk limited whiddon valley, barnstaple north devon, ex32 8ns, united kingdom - dimeticone - chewable tablet - dimeticone 125 mg - drugs for functional gastrointestinal disorders

Malta - angličtina - Malta Medicines Authority

forest laboratories uk limited whiddon valley, barnstaple north devon, ex32 8ns, united kingdom - dimeticone - soft capsule - dimeticone 125 mg - drugs for functional gastrointestinal disorders

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - zinc oxide, quantity: 15 mg/g; bemotrizinol, quantity: 10 mg/g; methylene bis-benzotriazolyl tetramethylbutylphenol, quantity: 10 mg/g - cream - excipient ingredients: decyl glucoside; white soft paraffin; peg-4 laurate; ethyl hydroxybenzoate; 1,3-butylene glycol; citric acid; safflower oil; stearyl alcohol; alkyl (c12-15) benzoate; purified water; xanthan gum; nicotinamide; propylene glycol; isopropyl palmitate; dimeticone 350; dichlorobenzyl alcohol; iodopropynyl butylcarbamate; light liquid paraffin; myristyl alcohol; cetyl alcohol; glycerol; methyl hydroxybenzoate; glyceryl monostearate; peg-100 stearate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - butyl methoxydibenzoylmethane, quantity: 25 mg/g; oxybenzone, quantity: 40 mg/g; octocrylene, quantity: 30 mg/g; octyl salicylate, quantity: 40 mg/g; homosalate, quantity: 50 mg/g - lotion - excipient ingredients: hexylene glycol; propyl hydroxybenzoate; polyester-7; bisabolol; methyl hydroxybenzoate; cetyl dimeticone; steareth-2; sodium polyacrylate; sarcosine; steareth-100; capryloyl glycine; neopentyl glycol diheptanoate; 1,3-butylene glycol; phenoxyethanol; styrene/acrylates copolymer; diethylhexyl-2,6-naphthalate; chlorphenesin; colloidal anhydrous silica; caprylyl glycol; propylene glycol; xanthan gum; octyl stearate; portulaca oleracea; cedrus atlantica; disodium edetate; trideceth-6; peg-8 laurate; purified water; dimeticone 2; alkyl (c12-15) benzoate; acrylates/dimethicone copolymer; butylated hydroxytoluene; cinnamomum verum; glucomannan; ethylhexylglycerin - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arbonne international llc - zinc oxide, quantity: 143.6 mg/g - lotion - excipient ingredients: medium chain triglycerides; myristic acid; triethoxycaprylylsilane; potassium sorbate; sodium benzoate; calendula officinalis; palmitic acid; aloe vera; dicaprylyl carbonate; phenoxyethanol; tapioca starch; potable water; stearic acid; chlorphenesin; candelilla wax; matricaria chamomilla; cetyl alcohol; polyglyceryl-4 isostearate; magnesium sulfate heptahydrate; coco-caprylate; silica dimethyl silylate; citric acid; carnauba wax; alkyl (c12-15) benzoate; glycerol; dl-alpha-tocopheryl acetate; sodium chloride; cetyl dimeticone; polyglyceryl-2 dipolyhydroxystearate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - dabigatran etexilate mesilate, quantity: 126.83 mg (equivalent: dabigatran etexilate, qty 110 mg) - capsule, hard - excipient ingredients: hyprolose; hypromellose; tartaric acid; dimeticone 350; potassium chloride; acacia; purified talc; titanium dioxide; carrageenan; indigo carmine; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). (see section 4.2 dose and method of administration for details of treatment duration). prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and for the prevention of recurrent dvt and pe in adults.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - dabigatran etexilate mesilate, quantity: 86.48 mg (equivalent: dabigatran etexilate, qty 75 mg) - capsule, hard - excipient ingredients: hypromellose; titanium dioxide; potassium chloride; purified talc; carrageenan; tartaric acid; hyprolose; purified water; acacia; dimeticone 350; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). (see section 4.2 dose and method of administration for details of treatment duration). prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and for the prevention of recurrent dvt and pe in adults.